Craniofacial and Neurological Phenotype in a Case of Oculodentodigital Syndrome.


Journal

Advances in experimental medicine and biology
ISSN: 0065-2598
Titre abrégé: Adv Exp Med Biol
Pays: United States
ID NLM: 0121103

Informations de publication

Date de publication:
2021
Historique:
entrez: 13 1 2022
pubmed: 14 1 2022
medline: 15 1 2022
Statut: ppublish

Résumé

Oculodentodigital syndrome (ODDS) is a rare genetic disorder caused by mutations in the gap junction GJA1 gene encoding connexin-43 (chromosome 6q22). A typical ODDS case is presented. A 40-year-old male patient was examined neurologically and genetically. He had a history of recent parieto-occipital leukodystrophy, some episodes of temporary hearing loss, and characteristic facial features of ODDS. Sequencing of the GJA1 gene was performed in patient's total genomic DNA sample isolated from peripheral blood cells. A novel heterozygous missense mutation (443G>A) was identified in the GJA1 gene, resulting in coding for a different amino acid (Arg148Gln). The molecular genetic analysis confirmed the diagnosis of ODDS. The novel mutation, located within a calmodulin binding region of connexin-43, probably affects proper channel function.

Identifiants

pubmed: 35023121
doi: 10.1007/978-3-030-78787-5_39
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

325-329

Informations de copyright

© 2021. The Author(s), under exclusive license to Springer Nature Switzerland AG.

Références

De Bock M, Kerrebrouck M, Wang N, Leybaert L (2013) Neurological manifestations of oculodentodigital dysplasia: a Cx43 channelopathy of the central nervous system. Front Pharmacol 4:120
pubmed: 24133447 pmcid: 3783840
Doshi D, Limdi P, Parekh N, Gohil N (2016) Oculodentodigital dysplasia. Indian J Ophthalmol 64:227
doi: 10.4103/0301-4738.180191
Wang Z, Sun L, Wang P et al (2019) Novel ocular findings in oculodentodigital dysplasia (ODDD): a case report and literature review. Ophthalmic Genet 40:54–59
doi: 10.1080/13816810.2019.1571616
Harting I, Karch S, Moog U et al (2019) Oculodentodigital dysplasia: a hypomyelinating leukodystrophy with a characteristic MRI pattern of brain stem involvement. Am J Neuroradiol 40:903–907
doi: 10.3174/ajnr.A6051
Tumminelli G, Di Donato I, Guida V et al (2015) Oculodentodigital dysplasia with massive brain calcification and a new mutation of GJA1 gene. J Alzheimers Dis 49:27–30
doi: 10.3233/JAD-150424
Loddenkemper T, Grote K, Evers S et al (2002) Neurological manifestations of the oculodentodigital dysplasia syndrome. J Neurol 249:584–595
doi: 10.1007/s004150200068
Paznekas WA, Karczeski B, Vermeer S et al (2009) GJA1 mutations, variants, and connexin 43 dysfunction as it relates to the oculodentodigital dysplasia phenotype. Hum Mutat 30:724–733
doi: 10.1002/humu.20958
Furuta N, Ikeda M, Hirayanagi K et al (2012) A novel GJA1 mutation in oculodentodigital dysplasia with progressive spastic paraplegia and sensory deficits. Intern Med 51:93–98
doi: 10.2169/internalmedicine.51.5770
Porntaveetus T, Srichomthong C, Ohazama A et al (2017) A novel GJA1 mutation in oculodentodigital dysplasia with extensive loss of enamel. Oral Dis 23:795–800
doi: 10.1111/odi.12663
Choi J, Yang A, Song A et al (2018) Oculodentodigital dysplasia with a novel mutation in GJA1 diagnosed by targeted gene panel sequencing: a case report and literature review. Ann Clin Lab Sci 48:776–781
pubmed: 30610049
Constantinides VC, Paraskevas GP, Kalogera S, Yapijakis C, Kapaki E (2021) Hot cross bun sign and prominent cerebellar peduncle involvement in a patient with oculodentodigital dysplasia. Neurol Sci 42(1):343–345
doi: 10.1007/s10072-020-04569-1
Richardson R, Donnai D, Meire F, Dixon MJ (2004) Expression of Gja1 correlates with the phenotype observed in oculodentodigital syndrome/type III syndactyly. J Med Genet 41:60–67
doi: 10.1136/jmg.2003.012005

Auteurs

Christos Yapijakis (C)

Unit of Orofacial Genetics, First Department of Pediatrics, National Kapodistrian University of Athens, "Aghia Sophia" Children's Hospital, Athens, Greece. cyapi@med.uoa.gr.
Department of Oral and Maxillofacial Surgery, School of Medicine, National and Kapodistrian University of Athens, Attikon Hospital, Athens, Greece. cyapi@med.uoa.gr.
Department of Molecular Genetics, Cephalogenetics Diagnostic Center, Athens, Greece. cyapi@med.uoa.gr.

Stefania Kalogera (S)

Department of Molecular Genetics, Cephalogenetics Diagnostic Center, Athens, Greece.

Antonia Angelopoulou (A)

Department of Molecular Genetics, Cephalogenetics Diagnostic Center, Athens, Greece.

Georgios Paraskevas (G)

First Department of Neurology, School of Medicine, National and Kapodistrian University of Athens, Eginition Hospital, Athens, Greece.

Elisabeth Kapaki (E)

First Department of Neurology, School of Medicine, National and Kapodistrian University of Athens, Eginition Hospital, Athens, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH